Rallybio Corporation (RLYB) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
RLYB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RLYB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -9511.9% | -9084.1% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export RLYB earnings history in CSV or JSON format
Free sign-in required to download data
Rallybio Corporation (RLYB) Earnings Overview
As of May 8, 2026, Rallybio Corporation (RLYB) reported trailing twelve-month net income of -$14M, reflecting +27.7% year-over-year growth. The company earned $-2.52 per diluted share over the past four quarters, with a net profit margin of -9084.1%.
Looking at the long-term picture, RLYB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2019.
Rallybio Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$464M net income), PRAX (-$327M net income), KYMR (-$315M net income, -794.4% margin), RLYB has comparable earnings metrics. Compare RLYB vs IMVT →
RLYB Earnings vs Peers
Earnings metrics vs comparable public companies
RLYB Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$58M | +22.5% | -$60M | $-10.64 | -9084.1% | -9511.9% |
| 2023 | -$75M | -11.9% | -$79M | $-14.72 | - | - |
| 2022 | -$67M | -41.8% | -$68M | $-16.72 | - | - |
| 2021 | -$47M | -77.8% | -$46M | $-11.68 | - | - |
| 2020 | -$26M | -50.0% | -$25M | $-9.52 | - | - |
| 2019 | -$18M | - | -$18M | $-6.32 | - | - |
See RLYB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RLYB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RLYB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRLYB — Frequently Asked Questions
Quick answers to the most common questions about buying RLYB stock.
Is RLYB growing earnings?
RLYB EPS is $-2.52, with earnings growth accelerating to +27.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-14M.
What are RLYB's profit margins?
Rallybio Corporation net margin is -9084.1%, with operating margin at -9511.9%. Below-average margins reflect competitive or cost pressures.
How consistent are RLYB's earnings?
RLYB earnings data spans 2019-2024. The accelerating earnings trend is +27.7% YoY. Historical data enables comparison across business cycles.